John Ihayi Ogbu

Mr. John Ihayi Ogbu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2023 in Venereology
Verified
Journal Article
Open access
PDF file
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
AMAndre Luis Elias Moreira
Andre Luis Elias Moreira
CICélia Regina Malveste Ito
Célia Regina Malveste Ito
ECElson Costa
Elson Costa
RQRafaella Misael Queiroz
Rafaella Misael Queiroz
OSOsmar Nascimento Silva
Osmar Nascimento Silva
In recent years, the global resurgence of syphilis has posed significant challenges to public health. This sexually transmitted infection, caused by the bacterium Treponema pallidum, can have severe consequences if left untreated, including neurological and cardiovascular complications. Diagnosing syphilis is complex due to its diverse clinical presentations, necessitating a multifaceted approach, including serological, molecular, and direct techniques such as dark-field microscopy. Penicillin remains the primary and effective treatment, but emerging macrolide-resistant strains have spurred investigations into alternative antibiotics. Syphilis vaccine development faces unique hurdles, yet promising strategies are under investigation. Targeted prevention strategies focus on high-risk populations such as men who have sex with men, pregnant women, and individuals with multiple sexual partners. The integration of syphilis services into primary healthcare enhances accessibility, early detection, and treatment. Innovative point-of-care diagnostics offer rapid, sensitive testing, while ongoing vaccine research holds the potential for long-term prevention. Addressing the global burden of syphilis requires a multifaceted approach, encompassing immunological advancements, innovative diagnostics, targeted prevention, and primary healthcare integration. Collaborative efforts between governments, healthcare systems, researchers, and communities are essential to effectively combat syphilis, striving toward a syphilis-free future that promotes better sexual health and overall well-being.

30 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LLLetícia Henrique Lima
Letícia Henrique Lima
MGMarcos Willian Francelino Gomes
Marcos Willian Francelino Gomes
TCThays Siqueira de Sá Curado
Thays Siqueira de Sá Curado
LNLara Marques Naves
Lara Marques Naves
SMStefanne Madalena Marques
Stefanne Madalena Marques
Gustavo Rodrigues PedrinoGustavo Rodrigues Pedrino
Gustavo Rodrigues Pedrino
Background: Bioactivity assessments of plant-derived products can benefit human and animal health, especially in regions with vast plant diversity. This study focused on chemical and cardiovascular analyses of Erythroxylum campestre A. St. Hil. leaf extracts. Methods: High-performance liquid chromatography, liquid chromatography coupled with mass spectrometry, and nuclear magnetic resonance spectroscopy were used to elucidate the structures of the flavonoids in E. campestre. The E. campestre methanolic fraction (ECM-ppt-M; at doses of 1, 2, 3, and 6 mg∙kg−1 or vehicle) was administered intravenously to normotensive and spontaneously hypertensive rats (SHRs), and we recorded the mean arterial pressure (MAP), heart rate (HR), renal vascular resistance (RVR), and aortic vascular resistance (AVC). Results: The ECM-ppt-M extract demonstrated significant antihypertensive activity, as evidenced by reductions in MAP, RVR, and AVR, with effects that were particularly pronounced in SHRs. Following the establishment of these cardiovascular effects, phytochemical analysis revealed the presence of glycosylated flavonoids, which are likely contributors to the observed antihypertensive properties of the extract. Conclusions: The notable reductions in MAP and vascular resistance observed with ECM-ppt-M treatment suggest its antihypertensive effect. These findings demonstrate the potential therapeutic value of this extract with regard to the treatment of hypertension. Future studies on ECM may provide a promising therapeutic alternative capable of reducing the risk of toxicity and adverse effects associated with synthetic drugs.

16 June 2023 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
FAFunmileyi Olubajo Awobajo
Funmileyi Olubajo Awobajo
JOJohn Ihayi Ogbu
John Ihayi Ogbu
Abdullahi Adeyinka AdejareAbdullahi Adeyinka Adejare
Abdullahi Adeyinka Adejare
GAGrace Akpanika
Grace Akpanika
CEChiamaka Egede
Chiamaka Egede
BTBukola Timothy
Bukola Timothy
Introduction and objective: High blood pressure is an important risk factor for heart-related disease. Combining dietary adjustments with standard drugs in the therapy of heart diseases have gained attention. Genistein, a soy isoflavone, has many biological effects but its role in blood...

31 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
JFJames Oluwagbamigbe Fajemiroye
James Oluwagbamigbe Fajemiroye
AMAndre Luis Elias Moreira
Andre Luis Elias Moreira
CICélia Ito
Célia Ito
ECElson Costa
Elson Costa
RQRafaella Misael Queiroz
Rafaella Misael Queiroz
OSOsmar Nascimento Silva
Osmar Nascimento Silva
Syphilis continues to be a significant global health concern, and understanding the latest advancements in immunology and pharmacological treatment is crucial for effective disease management. This review article provides an in-depth exploration of these advancements, aiming to contribute to the growing body of knowledge on syphilis research. The epidemiology of syphilis sets the stage for this review, highlighting the persistent burden of the disease worldwide. Current trends and challenges in disease control are discussed, shedding light on the need for comprehensive prevention strategies and improved surveillance systems. The immunological aspects of syphilis are the focus of this review. The intricate interplay between the host immune response and the evasive strategies employed by Treponema pallidum, the causative agent of syphilis, are explored. These include the mechanisms of immune evasion, the role of adaptive and innate immunity, and the development of immune-mediated tissue damage. The article also highlights advancements in diagnostic methods, with emphasis on the importance of accurate and timely detection. From traditional serological tests to the emergence of novel molecular and point-of-care assays, these developments have significantly improved the efficiency and accuracy of syphilis diagnosis. In terms of pharmacological treatment, the review covers the current recommendations and emerging strategies for managing syphilis infections. The challenges posed by antimicrobial resistance are addressed, emphasizing the importance of appropriate treatment regimens and close monitoring of therapeutic efficacy. Looking to the future, this review highlights the potential of vaccine development as a preventive measure against syphilis. Promising vaccine candidates and ongoing research efforts are discussed, offering hope for an effective means of disease prevention. In conclusion, this comprehensive review explores the advancements in syphilis research, from the understanding of immunological complexities to the development of innovative treatment strategies. By collectively advancing our knowledge, we can strive towards better disease management and minimize the impact of syphilis on global public health.

1 April 2026 in In Silico Pharmacology
Verified
Journal Article
Closed access
PDF file
FAFunmileyi O. Awobajo
Funmileyi O. Awobajo
JOJohn Ihayi Ogbu
John Ihayi Ogbu
DADavid O. Adekunle
David O. Adekunle
FOFaith E. Olujinmi
Faith E. Olujinmi
OOOladapo J. Olaosebikan
Oladapo J. Olaosebikan
GOGodwin Oladele Olutona
Godwin Oladele Olutona

1 January 2026 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
JOJohn Ihayi Ogbu
John Ihayi Ogbu
EOEfe Omorodion-Osagie
Efe Omorodion-Osagie
FAFunmileyi O. Awobajo
Funmileyi O. Awobajo
IOIbiyemi I. Olatunji-Bello
Ibiyemi I. Olatunji-Bello
The etiological contribution of male factors to infertility remains a significant concern in reproductive health. Natural dietary products are gaining attention as promising interventions to improve male infertility. This study investigates the effects of aqueous extract of Sesamum indicum L . (S. indicum) on male reproductive parameters and potential anti‐infertility mechanisms. Male Sprague–Dawley rats were randomly assigned to five groups: a control group (distilled water), two treatment groups receiving aqueous S. indicum extract (1.5 and 3.0 g/kg) for 30 days, and corresponding recovery groups. Reproductive organs were assessed for weight and sperm parameters. Blood serum was analyzed for luteinizing hormone (LH), testosterone, and lipid profile parameters. Incorporating in silico approaches, bioactive compounds of S. indicum were screened from a database, and their targets were predicted via network pharmacology, followed by functional enrichment analyses and molecular docking. Findings show that S. indicum significantly increased ( p < 0.05) the weights of the hearts, adrenal glands, livers, and accessory reproductive organs. Sperm count and morphology, as well as LH and testosterone levels, were significantly increased ( p < 0.05). Network pharmacology identified linoleic acid, oleic acid, biotin, and esculentic acid as key contributors to the extract’s anti‐infertility effects, potentially via interactions with EGFR, HIF1, BCL2, TNF, and AKT1. These interactions, supported by favorable binding affinities, may involve antioxidative pathways. Although the exposure duration, differences in extraction methods, paucity of experimental molecular data, and algorithmic constraints represent potential limitations, the present findings provide pharmacological insights into the therapeutic role of S. indicum in male infertility.